Teva Pharmaceutical Indus Market Sentiment

Teva Pharmaceutical Industries Ltd

TEVANYSE

Trade with Public

$40.72

-0.53-1.28%

最終更新: Oct 15, 4:23 AM

$40.86

-0.39-0.95%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Teva Pharmaceutical Indus Market Sentiment - Benzinga

Teva Pharmaceutical Indus Market Sentiment

Market sentiment signals for Teva Pharmaceutical Indus (TEVA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.6% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

—

Avg Consensus PT

$40

-2.8%

Highest Price Target

$55

+34.6%

TD Cowen

Lowest Price Target

$11

-73.1%

Goldman Sachs

Short Interest

2.6%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 12, 2026	JP Morgan	Chris Schott—	+22.4%	$40 → $50	Maintained	Overweight
Oct 1, 2026	TD Cowen	Joseph Thome—	+34.6%	$55	Initiate	Buy
Sep 23, 2026	Oppenheimer	Les Sulewski—	+22.4%	$50	Initiate	Outperform
Sep 9, 2026	Leerink Partners	Daniel Clark—	+10.1%	$45	Initiate	Outperform
Sep 4, 2026	UBS	Ashwani Verma—	+17.5%	$42 → $48	Maintained	Buy
Aug 12, 2026	Barclays	Glen Santangelo—	+2.8%	$40 → $42	Maintained	Overweight
Jul 28, 2026	Piper Sandler	David Amsellem—	+7.7%	$42 → $44	Maintained	Overweight
May 6, 2026	Barclays	Glen Santangelo—	-2.1%	$38 → $40	Maintained	Overweight
Apr 30, 2026	JP Morgan	Chris Schott—	-2.1%	$35 → $40	Maintained	Overweight
Apr 30, 2026	UBS	Ashwani Verma—	+2.8%	$36 → $42	Maintained	Buy
Apr 30, 2026	Piper Sandler	David Amsellem—	+2.8%	$41 → $42	Maintained	Overweight
Apr 30, 2026	Truist Securities	Les Sulewski—	+10.1%	$42 → $45	Maintained	Buy
Apr 9, 2026	B of A Securities	Jason Gerberry—	+2.8%	$38 → $42	Maintained	Buy
Mar 4, 2026	Piper Sandler	David Amsellem—	+0.3%	$40 → $41	Maintained	Overweight
Feb 18, 2026	Truist Securities	Les Sulewski—	+2.8%	$38 → $42	Maintained	Buy
Feb 9, 2026	Goldman Sachs	Matt Dellatorre—	+10.1%	$36 → $45	Maintained	Buy
Jan 30, 2026	Barclays	Glen Santangelo—	-7.0%	$35 → $38	Maintained	Overweight
Jan 29, 2026	Scotiabank	Louise Chen—	-2.1%	$35 → $40	Maintained	Sector Outperform
Jan 29, 2026	Truist Securities	Les Sulewski—	-7.0%	$36 → $38	Maintained	Buy
Jan 6, 2026	Jefferies	Glen Santangelo—	-2.1%	$29 → $40	Maintained	Buy
Dec 22, 2025	Piper Sandler	David Amsellem—	-2.1%	$30 → $40	Maintained	Overweight
Dec 19, 2025	Goldman Sachs	Matt Dellatorre—	-14.3%	$31 → $35	Maintained	Buy
Dec 16, 2025	JP Morgan	Chris Schott—	-14.3%	$28 → $35	Maintained	Overweight
Dec 9, 2025	B of A Securities	Jason Gerberry—	-21.7%	$29 → $32	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	-14.3%	$35	Initiate	Overweight